Skip to Content
AP National

Pfizer CEO on moving beyond COVID vaccines to become a leader in cancer and obesity treatments

By
Published 8:49 AM

AP Health Writer

WASHINGTON (AP) — Pfizer’s CEO Albert Bourla is trying to reposition the global pharmaceutical giant for a post-pandemic world. Two years ago, Pfizer recorded an unprecedented $100 billion in annual sales from its COVID-19 vaccine and antiviral Paxlovid. Lofty expectations for continuing sales of vaccines and antivirals have fallen flat, forcing the company to lay off staff and cut costs. Bourla spoke with The Associated Press about the company’s new focus on specialty cancer drugs and obesity treatments.

Article Topic Follows: AP National

Jump to comments ↓

Author Profile Photo

Associated Press

BE PART OF THE CONVERSATION

KIFI Local News 8 is committed to providing a forum for civil and constructive conversation.

Please keep your comments respectful and relevant. You can review our Community Guidelines by clicking here

If you would like to share a story idea, please submit it here.

Skip to content